SINGAPORE | HONG KONG | LONDON
Principal capital.
Strategic transactions.
Public-market execution.
Severn Capital is a principal-led private investment and strategic transactions platform headquartered in Singapore, with a presence in Hong Kong and London.
The firm invests its own capital and works selectively across private investments, London-listed company transactions and selected strategic mandates, with a focus on healthcare, diagnostics, technology and selected real assets.
THE FIRM
Discreet.
Principal-led.
Long-term.
Severn Capital operates at the intersection of Asian capital, London public markets and private investment.
The firm acts as principal, committing its own capital alongside selected partners and focusing on situations where capital, execution and opportunity are closely aligned.
Its activities span healthcare and diagnostics, technology, laboratory services, selected real assets and listed-company transactions, drawing on long-standing relationships and operating experience across Asia and Europe.
About Severn Capital →GEOGRAPHIC REACH
Headquartered in Singapore.
Present in Hong Kong
and London.
Severn operates between Asian capital and the London public markets, investing in and pursuing transactions involving businesses, shareholders and listed platforms across both regions.
INVESTMENT FOCUS
Four areas of sustained focus.
Severn Capital focuses on a limited number of sectors where it has direct experience, trusted relationships and a clear view of public-market or cross-border strategic relevance.
01
Public Markets
Listed-company transactions, acquisition platforms, recapitalisations, block trades and strategic equity positions across the London Stock Exchange, AIM and selected Asian markets.
02
Healthcare & Diagnostics
Principal investment and strategic involvement across medtech, molecular diagnostics, laboratory services and healthcare businesses with international growth potential.
03
Technology
Selected exposure to technology businesses with scalable platforms, cross-border relevance and credible pathways to institutional capital or public-market execution.
04
Real Assets
Selective principal investment in residential and commercial real estate, principally in Australia, with selected interest in UK opportunities where long-term fundamentals are compelling.
Leadership
FOUNDER & PRINCIPAL
Kane Black
Kane Black is the founder and principal of Severn Capital. Based in Singapore, he has spent more than 20 years in Asia and is a Singapore Permanent Resident.
His experience spans public markets, medical technology, diagnostics, healthcare services, technology and cross-border investment, with a particular focus on the intersection of Asia and London capital markets.
He was formerly Chief Executive Officer of London Stock Exchange-listed Ikigai Ventures Limited, where he led the company's transaction strategy through to the admission of Dotlines Global to AIM at a market capitalisation of £57.9 million, creating a UK and Southeast Asia focused technology platform.
Kane previously served as Chief Executive Officer of INEX Innovate, a Singapore-based medtech and diagnostics company formed through a US$72 million merger backed by institutional investors including Genting Berhad and Enterprise Singapore.
He has been appointed as Strategic Adviser to London-listed acquisition companies and remains active across healthcare, laboratory services, technology and selected public-market transactions.
He was named EY Entrepreneur Of The Year – Biotechnology in Singapore in 2022 and is a member of the NUS Medicine International Council.
Full Profile →
Private investment and transaction enquiries.
Severn Capital engages selectively with founders, boards, shareholders, institutional investors, family offices and corporate counterparties.
The firm welcomes approaches concerning private investments, London-listed company transactions, acquisition vehicles, strategic mandates and cross-border opportunities across Asia and the UK.
Get in Touch